Cervical cancer prevention and treatment in Latin America.
Cervical cancer is a preventable disease with a known etiology (human papillomavirus), effective preventive vaccines, excellent screening methods, and a treatable pre-invasive phase. Surgery is the primary treatment for pre-invasive and early-stage disease and can safely be performed in many low-resource settings. However, cervical cancer rates remain high in many areas of Latin America. This article presents a number of evidence-based strategies being implemented to improve cervical cancer outcomes in Latin America.
The University of Texas MD Anderson Cancer Center, Houston, Texas.
Melissa S
MS
Lopez
The University of Texas MD Anderson Cancer Center, Houston, Texas.
Ellen S
ES
Baker
Basic Health International (BHI), San Salvador, El Salvador.
Mauricio
M
Maza
Hospital de Cancer de Barretos, Barretos, Brazil.
Georgia
G
Fontes-Cintra
Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Peru.
Aldo
A
Lopez
Hospital del Seguro Social, Matamoros, Mexico.
Juan M
JM
Carvajal
Universidad de la Republica, Montevideo, Uruguay.
Fernanda
F
Nozar
Universidad de la Republica, Montevideo, Uruguay.
Veronica
V
Fiol
The University of Texas MD Anderson Cancer Center, Houston, Texas.
Kathleen M
KM
Schmeler
D005260:Female; D006297:Health Services Accessibility; D006801:Humans; D007843:Latin America / Q000453:epidemiology; D008403:Mass Screening; D030361:Papillomavirus Infections / Q000175:diagnosis; D053918:Papillomavirus Vaccines / Q000627:therapeutic use; D011322:Primary Prevention; D019114:Remote Consultation; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000628:therapy* / Q000821:virology
D053918:Papillomavirus Vaccines
LMICs; Latin America; cervical cancer; surgical training; telementoring